Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference and 2006 Citigroup Healthcare Conference
09 February 2006 - 12:30AM
PR Newswire (US)
CAMBRIDGE, Mass., Feb. 8 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that
Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief
executive officer, will present a corporate overview at the
upcoming BIO CEO & Investor Conference on Wednesday, February
15, 2006 at 12:00 p.m. at the Waldorf Astoria, New York and at the
2006 Citigroup Healthcare Conference on Tuesday, February 28, 2006
at 3:05 p.m. at the Mayflower Hotel, Washington, D.C. The live and
archived webcasts of the presentations can be accessed under
"Calendar of Events" in the Idenix Investor Center at
http://www.idenix.com/. The archived replays will be available on
the Idenix website for two weeks following the presentations. About
Idenix Idenix Pharmaceuticals, Inc. is a biopharmaceutical company
engaged in the discovery and development of drugs for the treatment
of human viral and other infectious diseases. Idenix's current
focus is on the treatment of infections caused by hepatitis B
virus, hepatitis C virus and human immunodeficiency virus (HIV).
Idenix's headquarters are located in Cambridge, Massachusetts and
it has drug discovery operations in Montpellier, France and
Cagliari, Italy. Contacts: Idenix Pharmaceuticals, Inc. Amy
Sullivan (617) 995-9838 Teri Dahlman (617) 995-9905 First Call
Analyst: FCMN Contact: DATASOURCE: Idenix Pharmaceuticals, Inc.
CONTACT: Amy Sullivan, +1-617-995-9838, or Teri Dahlman,
+1-617-995-9905, both of Idenix Pharmaceuticals, Inc. Web site:
http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals (MM) News Articles